Market Cap

Trillium Therapeutics Inc. Market Capitalization:

C$2.30 Billion

CAD as of Nov. 1, 2021

US$1.82 Billion

business Trillium Therapeutics Inc. Company Profile

Trillium Therapeutics Inc. Main Stock Listing

TSX: TRIL

Market Capitalization History of Trillium Therapeutics Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Trillium Therapeutics Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2021 C$1.76 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Trillium Therapeutics Inc. Categories

Canada languages Healthcare languages Biotechnology
Canada Healthcare Canada Biotechnology

Stocks & Indices

Trillium Therapeutics Inc. has the following listings and related stock indices.


Stock: TSX: TRIL

Stock: NASDAQ: TRIL

Stock: FSX: R5WP

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.